Brief: Avenue Therapeutics Says CEO To Resign
30/03/2022 22:07
March 30 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS - ON MARCH 28, , LUCY LU, NOTIFIED CO
THAT
SHE WAS RESIGNING FROM HER ROLE AS CO’S PRESIDENT AND CEO
* AVENUE THERAPEUTICS - DAVID JIN, WILL BEGIN ACTING AS
COMPANY’S
INTERIM PRINCIPAL EXECUTIVE OFFICER AS OF MARCH 31, 2022
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary